ATC code - L01F
SpainDrugs with code L01F
-
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg ATC code: L01F, L01FD, L01FD01
Manufacturer: Samsung Bioepis Nl B.V.
-
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg ATC code: L01F, L01FD, L01FD01
Manufacturer: Samsung Bioepis Nl B.V.
-
Form: solution for infusion, concentrate
Active substance Dosage nivolumab 107 mg/dosis ATC code: L01F, L01FF, L01FF01
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Form: solution for infusion, concentrate
Active substance Dosage nivolumab 47 mg/dosis ATC code: L01F, L01FF, L01FF01
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Form: solution for infusion, concentrate
Active substance Dosage bevacizumab 25 mg ATC code: L01F, L01FG, L01FG01
Manufacturer: Stada Arzneimittel Ag
-
Form: powder for concentrate for solution for infusion
Active substance Dosage enfortumab vedotin 20 mg ATC code: L01F, L01FX, L01FX13
Manufacturer: Astellas Pharma Europe B.V.
-
Form: powder for concentrate for solution for infusion
Active substance Dosage enfortumab vedotin 30 mg ATC code: L01F, L01FX, L01FX13
Manufacturer: Astellas Pharma Europe B.V.
-
Form: solution for infusion, concentrate
Active substance Dosage pertuzumab 30,0 mg ATC code: L01F, L01FD, L01FD02
Manufacturer: Roche Registration Gmbh
-
Form: solution for injection
Active substance Dosage pertuzumab 1200 mg trastuzumab 600 mg ATC code: L01F, L01FY, L01FY01
Manufacturer: Roche Registration Gmbh
-
Form: solution for injection
Active substance Dosage pertuzumab 600 mg trastuzumab 600 mg ATC code: L01F, L01FY, L01FY01
Manufacturer: Roche Registration Gmbh
-
Form: powder for concentrate for solution for infusion
Active substance Dosage polatuzumab vedotina 140 mg ATC code: L01F, L01FX, L01FX14
Manufacturer: Roche Registration Gmbh
-
Form: powder for concentrate for solution for infusion
Active substance Dosage polatuzumab vedotina 30 mg ATC code: L01F, L01FX, L01FX14
Manufacturer: Roche Registration Gmbh
-
Form: solution for infusion, concentrate
Active substance Dosage mogamulizumab 20 mg ATC code: L01F, L01FX, L01FX09
Manufacturer: Kyowa Kirin Holdings B.V.
-
Form: solution for infusion, concentrate
Active substance Dosage dinutuximab beta 4,5 mg ATC code: L01F, L01FX, L01FX06
Manufacturer: Recordati Netherlands B.V.
-
Form: solution for infusion, concentrate
Active substance Dosage rituximab 10 mg ATC code: L01F, L01FA, L01FA01
Manufacturer: Sandoz Gmbh
-
Form: solution for infusion, concentrate
Active substance Dosage rituximab 10 mg ATC code: L01F, L01FA, L01FA01
Manufacturer: Sandoz Gmbh
-
Form: solution for infusion, concentrate
Active substance Dosage rituximab Igual a 10 mg mg ATC code: L01F, L01FA, L01FA01
Manufacturer: Pfizer Europe Ma Eeig
-
Form: solution for infusion, concentrate
Active substance Dosage rituximab 500 mg ATC code: L01F, L01FA, L01FA01
Manufacturer: Pfizer Europe Ma Eeig
-
Form: solution for injection
Active substance Dosage amivantamab 1600 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection
Active substance Dosage amivantamab 2240 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for infusion, concentrate
Active substance Dosage amivantamab 350 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for infusion, concentrate
Active substance Dosage isatuximab 20 mg ATC code: L01F, L01FC, L01FC02
Manufacturer: Sanofi Winthrop Industrie
-
Form: solution for injection
Active substance Dosage talquetamab 3 mg ATC code: L01F, L01FX, L01FX29
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection
Active substance Dosage talquetamab 40 mg ATC code: L01F, L01FX, L01FX29
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for infusion, concentrate
Active substance Dosage atezolizumab 1200 mg ATC code: L01F, L01FF, L01FF05
Manufacturer: Roche Registration Gmbh
-
Form: solution for injection
Active substance Dosage atezolizumab 1875 mg ATC code: L01F, L01FF, L01FF05
Manufacturer: Roche Registration Gmbh
-
Form: solution for infusion, concentrate
Active substance Dosage atezolizumab 840 mg ATC code: L01F, L01FF, L01FF05
Manufacturer: Roche Registration Gmbh
-
Form: solution for injection
Active substance Dosage teclistamab 30 mg ATC code: L01F, L01FX, L01FX24
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection
Active substance Dosage teclistamab 153 mg ATC code: L01F, L01FX, L01FX24
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection, concentrate
Active substance Dosage epcoritamab 5 mg/ml ATC code: L01F, L01FX, L01FX27
Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
Form: solution for injection
Active substance Dosage epcoritamab 60 mg/ml ATC code: L01F, L01FX, L01FX27
Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
Form: solution for infusion, concentrate
Active substance Dosage tislelizumab 10 mg ATC code: L01F, L01FF, L01FF09
Manufacturer: Beone Medicines Ireland Limited
-
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg ATC code: L01F, L01FD, L01FD01
Manufacturer: Pfizer Europe Ma Eeig
-
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg ATC code: L01F, L01FD, L01FD01
Manufacturer: Pfizer Europe Ma Eeig
-
Form: powder for concentrate for solution for infusion
Active substance Dosage sacituzumab govitecan 200 mg ATC code: L01F, L01FX, L01FX17
Manufacturer: Gilead Sciences Ireland Unlimited Company
-
Form: solution for infusion, concentrate
Active substance Dosage rituximab 100 mg ATC code: L01F, L01FA, L01FA01
Manufacturer: Celltrion Healthcare Hungary Kft.
-
Form: solution for infusion, concentrate
Active substance Dosage rituximab 500 mg ATC code: L01F, L01FA, L01FA01
Manufacturer: Celltrion Healthcare Hungary Kft.
-
Form: solution for infusion, concentrate
Active substance Dosage panitumumab 20 mg ATC code: L01F, L01FE, L01FE02
Manufacturer: Amgen Europe B.V.
-
Form: solution for infusion, concentrate
Active substance Dosage panitumumab 20 mg ATC code: L01F, L01FE, L01FE02
Manufacturer: Amgen Europe B.V.
-
Form: solution for infusion, concentrate
Active substance Dosage bevacizumab 100 mg ATC code: L01F, L01FG, L01FG01
Manufacturer: Celltrion Healthcare Hungary Kft.
-
Form: solution for infusion, concentrate
Active substance Dosage ipilimumab 213 mg ATC code: L01F, L01FX, L01FX04
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Form: solution for infusion, concentrate
Active substance Dosage ipilimumab 53,5 mg ATC code: L01F, L01FX, L01FX04
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg ATC code: L01F, L01FD, L01FD01
Manufacturer: Accord Healthcare S.L.U.
-
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg ATC code: L01F, L01FD, L01FD01
Manufacturer: Accord Healthcare S.L.U.
-
Form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 60 mg ATC code: L01F, L01FD, L01FD01
Manufacturer: Accord Healthcare S.L.U.
-
Form: solution for infusion, concentrate
Active substance Dosage bevacizumab 100 mg ATC code: L01F, L01FG, L01FG01
Manufacturer: Pfizer Europe Ma Eeig
-
Form: solution for infusion, concentrate
Active substance Dosage bevacizumab 400 mg ATC code: L01F, L01FG, L01FG01
Manufacturer: Pfizer Europe Ma Eeig